A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable?: Authors’ reply

  • Tausche, A-K
  • Schröder, H E

  • Section of Internal Medicine, Department of Rheumatology, University Clinic Carl Gustav Carus, Dresden University of Technology, Germany

Correspondence to: Dr A K Tausche [email protected]

Annals of the Rheumatic Diseases 64(3):p 516, March 2005.
Copyright © 2005 BMJ Publishing Group Ltd and European League Against Rheumatism